RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Hospira, Inc.

A collection of news and information related to Hospira, Inc. published by this site and its partners.

Top Hospira, Inc. Articles see all

Displaying items 1-5
  • Hospira talks for $5 billion tax inversion deal stall

    Hospira talks for $5 billion tax inversion deal stall
    Lake Forest-based drugmaker Hospira's talks to buy the medical nutrition unit of Danone and use the deal to move its tax domicile abroad have stalled, according to people familiar with the matter, as attempts by U.S. companies to relocate abroad and cut their tax bills draw growing criticism back home.
  • Chicago health tech hub accepting applications, names leaders

    Chicago health tech hub accepting applications, names leaders
    Matter, a not-for-profit health tech hub in downtown Chicago slated to open in early 2015, on Tuesday named a chief executive and said it's taking applications for new tenants. “What's been missing here in this (health technology) community is a...

    Durbin urges Hospira not to flee U.S.

    Durbin urges Hospira not to flee U.S.
    Sen. Dick Durbin has a new target as he tries to halt American firms from moving corporate headquarters overseas to cut their tax bills: Hospira, a Lake Forest-based company that makes injectable drugs and infusion products. The Democrat from Illinois...

    The day ahead in business

    The day ahead in business
    Reports: Second-quarter advance GDP, ADP employment survey for July Local earnings: Acco Brands Corp., Allstate Corp.,  Hospira Inc., Ingredion Inc., KapStone Paper & Packaging, Kraft Foods Group Inc., Littelfuse Inc., Nanophase Technologies Corp., R.R....

    Hospira beats profit estimates, raises 2014 outlook

    Hospira beats profit estimates, raises 2014 outlook
    Hospira Inc., a pharmaceutical and medical device maker, posted a better-than-expected quarterly profit on higher sales of specialty injectable drugs, and raised its full-year outlook. The company's net income more than doubled to $70.9 million, or 42...